University of Wisconsin-Madison Professor Zachary Morris discusses his research into the field of theranostics and the “team ...
In early September, Alpha Tau announced that it treated the first patient in its 30-patient US trial. This trial is set to ...
News-Medical.Net on MSN
New approach protects the brain from radiation-induced cognitive decline
While tremendous relief comes from successfully battling cancer, survivors can also experience cognitive impairments caused ...
Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types ...
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumours, such as thyroid, lymphomas or bone metastases, delivering radiation to tumorous lesions as part of a therapeutic strategy ...
Strand Therapeutics has raised $153 million in second-round financing that will be used to move its programmable mRNA therapies through clinical development. The Boston, US-based biotech recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback